Clinical Research Coordinator - Cardiovascular
About the job
- A bachelor's degree is required.
- At least two years of experience as a Clinical Research Coordinator.
- Familiarity with cardiovascular medical terminology and procedures, including electrocardiograms, echocardiograms, Holter monitors, and cardiac catheterization.
- Strong understanding of Good Clinical Practice and clinical trial processes.
- Ability to work independently and manage multiple priorities across sites.
- Strong organizational skills and high attention to detail.
- Strong interpersonal and communication skills with a patient-centered approach.
- Ability to problem-solve and adapt in a dynamic clinical environment.
- Proficiency with electronic data capture systems and Microsoft Office.
- Ability to travel to other hospital locations local to Rahway, New Jersey.
- Prospective on-site resources may be required to receive annual influenza inoculation and successfully pass a Mantoux Tuberculin Skin Test for Mycobacterium tuberculosis.
- Coordinate and execute day-to-day clinical trial activities across sites in accordance with the study protocol, Good Clinical Practice, and regulatory requirements.
- Work closely with the Principal Investigator to support study oversight, patient eligibility review, safety reporting, and protocol adherence for cardiovascular trials.
- Identify, screen, and consent eligible patients for cardiovascular studies, including studies involving acute cardiac events or chronic heart conditions.
- Schedule and manage patient visits, ensuring protocol compliance and timely completion of study procedures such as electrocardiograms, vital-sign monitoring, and blood draws.
- Serve as the primary point of contact for study participants, including meeting patients during visits and conducting follow-up communications.
- Accurately collect, document, and maintain study data in source documents and electronic systems such as electronic data capture and clinical trial management systems.
- Extract relevant clinical data from electronic medical records, focusing on cardiology reports, cardiac catheterization results, and echocardiogram findings.
- Ensure proper specimen collection, processing, storage, and shipment in compliance with protocol and laboratory requirements.
- Collaborate with investigators, site staff, cardiac catheterization laboratory personnel, and sponsor representatives to ensure smooth study conduct.
- Monitor patient safety and report adverse events according to protocol and regulatory guidelines, including cardiovascular-specific safety reporting.
- Maintain regulatory binders and ensure audit readiness.
- Support monitoring visits, audits, and inspections as needed.
- Manage device accountability for trials involving implantable cardiovascular devices or wearables such as Holter monitors.
- Prior experience working as a Clinical Research Coordinator in an academic medical center or community hospital setting.
- Experience in cardiovascular, cardiology, or vascular research studies.
- Healthcare, life sciences, or a related field as the bachelor's degree field.
About the company
Vitalief is a clinical trial solutions provider in New Brunswick, NJ that offers advisory and support services for pharmaceutical and healthcare clients. It helps plan and run clinical trials by recruiting top talent from the clinical research industry to ensure trials are completed successfully. Revenue comes from tailored advisory and support engagements rather than product sales. Vitalief differentiates itself with a people-first culture, investing in its team to deliver sustainable, high-quality services, and by adapting to industry changes such as increased telemedicine during COVID-19 to stay relevant and effective. The company’s goal is to support clients in delivering accurate, timely clinical trials that positively impact patient lives by providing skilled personnel and expert guidance.
Company Size
11-50
Company Stage
Early VC
Total Funding
$2M
Headquarters
New Brunswick, New Jersey
Founded
2021
Get referred to Vitalief
See people who can refer or advise you
Simplify's Take
What believers are saying
- August 2026 job postings show active hiring across New Brunswick, Newark, Rahway, and oncology.
- Vitalief’s trial-rescue and rapid-activation services fit persistent site turnover and study-startup delays.
- 2026 health-system positioning targets academic medical centers, acquired sites, and affiliated programs for expansion.
What critics are saying
- Vitalief disclosed only $2.75 million Series A on April 19, 2022; capital starvation limits scale.
- Services depend on sponsor and site outsourcing budgets; contract losses hit utilization immediately.
- AI-enabled rivals like Medidata and IQVIA can bundle software, squeezing Vitalief into commoditized labor.
What makes Vitalief unique
- Vitalief’s VELARA delivery platform centralizes consulting, resourcing, and managed services on August 22, 2026.
- Vitalief embeds teams across sponsors, CROs, and sites, with New Brunswick and King of Prussia offices.
- Vitalief Academy monetizes workforce upskilling, linking retention, performance, and clinical-trial execution since June 26, 2023.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
Paid Holidays
Paid Vacation
Performance Bonus
Company Equity
Growth & Insights and Company News
6 month growth
6%1 year growth
6%2 year growth
6%Novel Learning and Development Solution Targets Performance and RetentionNEW BRUNSWICK, N.J., June 26, 2023 /PRNewswire/ -- Vitalief, a leading consulting provider specializing in the research and clinical trial industry, is excited to announce the launch of Vitalief Academy, a suite of services, content, and technologies that offer competency enrichment and targeted learning and development curricula for professionals.The launch comes in response to the increasing demand for high-quality professionals to support the conduct of research and clinical trials. Vitalief Academy started as an internal initiative providing professional development and upskilling opportunities for Vitalief employees. As the concept evolved, the company recognized the unmet need for similar programs among clients who are looking to increase retention and improve performance. This realization led the team to commercialize the curriculum under the Vitalief Academy moniker.Vitalief Academy is more than a skills development platform; it is an incubator for success! -John Royer Tweet this"Vitalief Academy represents our continuing commitment to providing upskilling and professional development opportunities to research and clinical trial professionals," said David Moore, CEO of Vitalief. "It's an answer to the ongoing healthcare human capital epidemic that can have a significant and simultaneous impact on an organization's performance and their employee retention efforts. We're assembling top talent and using innovative technology to craft programs that will elevate competencies, inspire growth, and ultimately improve patient care."John Royer, newly appointed Vice President of Learning and Development, will lead the Academy's operations
NEW BRUNSWICK, N.J., June 1, 2023 /PRNewswire/ -- Vitalief, a leading consulting and functional service provider specializing in the research and clinical trial industry, is excited to announce the launch of its new Clinical Trials Office (CTO) and Study Activation services. The offerings encompass four key services: consulting, resourcing, managed services, and learning and development which are designed to address the most pressing challenges in clinical research.In their 2022 Site Landscape Survey, the Society for Clinical Research Sites found that "58% of respondents reported higher turnover in the last two years." This industry-wide trend toward high attrition rates has resulted in degraded processes based on outdated systems and an acute need for staff training and development. Vitalief's new services target the clinical trials office where the alignment of people, processes, and technologies is critical to research success."Our goal is to empower research organizations to achieve more," said David Moore, CEO of Vitalief. Tweet this"Our goal is to empower research organizations to achieve more," said David Moore, CEO of Vitalief. "These new services embody our commitment to tackling the most significant issues in the industry. With our CTO and Study Activation services, we're leveraging our expertise to provide innovative solutions to the areas where our clients need them the most."While the CTO services address the broader clinical trials office function with the organization, the Study Activation services focus on the specific activities that are required to start a study, including the coordination of review and approval cycles by various teams and individuals